Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy

AIDS and Behavior

Volumn 9, Issue 3, 2005, Pages 289-299

  Rusch, Melanie L ^a,f   Farzadegan, Homayoon ^b   Tarwater, Patrick M ^c   Safaeian, Mahboobeh ^b   Vlahov, David ^b,d   Strathdee, Steffanie A ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d NEW YORK ACADEMY OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ST PAUL S HOSPITAL   (Canada)

Author keywords

Behavior change; Condom use; IDU; Sexual risk

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONDOM; CONTROLLED STUDY; COUNSELING; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

ADULT; AIDS SERODIAGNOSIS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BALTIMORE; COHORT STUDIES; CONDOMS; COUNSELING; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 27744457473     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-005-9003-4     Document Type: Article

References (33)

1. Bruneau, J., Lamothe, F., Soto, J., Lachance, N., Vincelette, J., Vassal, A., and Franco, E. L. (2001). Sex-specific determinants of HIV infection among injection drug users in Montreal. Canadian Medical Association Journal, 164, 767-773.
2. Colfax, G. N., Buchbinder, S. P., Cornelisse, P. G. A., Vittinghoff, E., Mayer, K., and Celum, C. (2002). Sexual risk behaviours and implications for secondary HIV transmission during and after HIV seroconversion. AIDS, 16, 1529-1535.
3. Cusick, L. (1998). Non-use of condoms by prostitute women. AIDS Care, 10, 133-146.
4. Diggle, P. J., Liang, K., and Zeger, S. L. (1995). Analysis of longitudinal data. (2nd ed.) New York: Oxford University Press.
5. Dolezal, C., Meyer-Bahlburg, H. F. L., Liu, X., Ehrhardt, A. A., Exner, T. M., Rabkin, J. G., Gorman, J. M., Marder, K., and Stern, Y. (1999). Longitudinal changes in sexual risk behaviour among HIV+ and HIV- male injecting drug users. American Journal of Drug and Alcohol Abuse, 25, 281-303.
6. Donoghoe, M. C. (1992). Sex, HIV and the injecting drug users. British Journal of Addiction, 87, 405-416.
7. Dukers, N., Goudsmit, J., de Wit, J. B. F., Prins, M., Weverling, G., and Coutinho, R. A. (2001). Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS, 15, 369-378.
8. Dwyer, R., Richardson, D., Ross, M. W., Wodak, A., Miller, M. E., and Gold, J. (1994). A Comparison of HIV risk between women and men who inject drugs. AIDS Education and Prevention, 6, 379-389.
9. Erbelding, E. J., Stanton, D., Quinn, T. C., and Rompalo, A. (2000). Behavioural and biological evidence of persistent high-risk behaviour in an HIV primary care population. AIDS, 14, 297-301.
10. Jivasak-Apimas, S., Saba, J., Chandeying, V., Sakondhavat, C., Kiriwat, O., Rugpao, S., Rojanapithayakorn, W., and Fontanet, A. (2001). Acceptability of the female condom among sex workers in Thailand. Sexually Transmitted Diseases, 28, 648-654.
11. Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., and Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk factor analysis. The Lancet, 357, 1397-1401.
12. Macalino, G. E., Celentano, D. D., Latkin, C. A., Strathdee, S. A., and Vlahov, D. (2002). Risk behaviours by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Education and Prevention, 14, 367-378.
13. Maxwell, C., and Boyle, M. (1995). Risky heterosexual practices amongst women over 30: Gender, power and long term relationships. AIDS Care, 7, 277-293.
14. Metzger, D. S., and Navaline, H. (2003). HIV prevention among injection drug users: The need for integrated models. Journal of Urban Health, 80(4, Suppl 3), iii59-iii66.
15. Miller, C., Spittal, P. M., LaLiberte, N., Li, K., Tyndall, M., O'Shaughnessy, M., and Schechter, M. T. (2002). Females experiencing sexual and drug vulnerabilities are at elevated risk for hiv infection among youth who use injection drugs. Journal of Acquired Immune Deficiency Syndrome, 30, 335-341.
16. Mize, S. J. S., Robinson, B. E., Bockting, W. O., and Scheltema, K. E. (2002). Meta-analysis of the effectiveness of HIV prevention interventions for women. AIDS Care, 14, 163-180.
17. Nelson, K. E., Galai, N., Safaiean, M., Strathdee, S. A., Celentano, D. D., and Vlahov, D. (2002). Temporal trends in the incidence of human immunodeficiency virus and risk behaviour among injection drug users in Baltimore, Maryland, 1988-1998. American Journal of Epidemiology, 156, 641-653.
18. Rhodes, F., Corby, N. H., Wolitski, R. J., Tashima, N., Crain, C., Yankovich, D. R., and Smith, P. K. (1990). Risk behaviors and perceptions of AIDS among street injection drug users. Journal of Drug Education, 20, 271-288.
19. Rietmeijer, C. A., Kane, M. S., Simons, P. Z., Corby, N. H., Wolitski, R. J., Higgins, D. L., Judson, F. N., and Cohn, D. L. (1996). Increasing the use of bleach and condoms among injecting drug users in Denver: Outcomes of a targeted, community-level HIV prevention program. AIDS, 10, 291-298.
20. Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., Flores, S. A., Norman, L., Sweat, M. D., and Needle, R. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviours of drug users in the United States. Journal of Acquired Immune Deficiency Syndrome, 30, S73-S93.
21. Somlai, A. M., Kelly, J. A., McAuliffe, T. L., Ksobiech, K., and Hackl, K. L. (2003). Predictors of HIV sexual risk behaviors in a community sample of injections drug-using men and women. AIDS and Behavior, 7, 383-393.
22. Spittal, P. M., Craib, K. J. P., Wood, E., LaLiberte, N., Li, K., Tyndall, M., O'Shaughnessy, M., and Schechter, M. T. (2002). Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Canadian Medical Association Journal, 166, 891-899.
23. Sterk, C. E., Theall, K. P., Elifson, K. W., and Kidder, D. (2003). HIV risk reduction among African-American women who inject drugs: A randomized controlled trial. AIDS and Behavior, 7, 73-86.
24. Strathdee, S. A., Celentano, D. D., Shah, N. G., Lyles, C., Stambolis, V. A., Macalino, G. E., Nelson, K. E., and Vlahov, D. (1999). Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health, 76, 448-460.
25. Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., and Nelson, K. E. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users. Archives of Internal Medicine, 161, 1281-1288.
26. Strathdee, S. A., and Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80(4, Suppl 3):iii7-iii14.
27. Tun, W., Celentano, D. D., Vlahov, D., and Strathdee, S. A. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS, 17, 1953-1962.
28. Tun, W., Gange, S. J., Vlahov, D., Strathdee, S. A., and Celentano, D. D. (2004). Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clinical Infectious Diseases, 38, 1167-1174.
29. Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., and Polk, B. F. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Research Monographs, 109, 75-100.
30. Vlahov, D., Safaien, M., Lai, S., Strathdee, S. A., Johnson, L., Sterling, T., and Celentano, D. D. (2001). Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS, 15, 2311-2316.
31. Watters, J. K. (1994). Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. Journal of Acquired Immune Deficiency Syndrome, 7, 1276-1281.
32. Wingood, G. M., and DiClemente, R. J. (1998). The influence of psychosocial factors, alcohol, drug use on African-American women's high-risk sexual behavior. American Journal of Preventive Medicine, 15, 54-59.
33. Witte, S. S., Wada, T., El-Bassel, N., Gilbert, L., and Wallace, J. (2000). Predictors of female condom use among women exchanging street sex in New York City. Sexually Transmitted Diseases, 27, 93-100.